Prostaglandin E1 in peripheral vascular disease: A PET study of muscular blood flow

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 58, Issue 2, 1998, Pages 109-117

  Schellong, S M ^a,b   Burchert, W ^a   Boger R M ^a   Creutzig, A ^a   Hundeshagen, H ^a   Alexander, K ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

133Xe clearance; 15O water; Flow tracer; Nutritional blood flow; Peripheral vascular disease; Skeletal muscle; Therapy

Indexed keywords

OXYGEN 15; PROSTAGLANDIN E1; PROSTAVASIN;

ADULT; AGED; ARTERIOGRAPHY; ARTERY OCCLUSION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FEMORAL ARTERY; HUMAN; HUMAN EXPERIMENT; HYPEREMIA; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEG ISCHEMIA; LOW BACK PAIN; MALE; MUSCLE BLOOD FLOW; NORMAL HUMAN; PERIPHERAL VASCULAR DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TECHNIQUE;

ADULT; AGED; ALPROSTADIL; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; LEG; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PERIPHERAL VASCULAR DISEASES; REGIONAL BLOOD FLOW; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031947485     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365519850186689     Document Type: Article

References (36)

1. 1 in severe peripheral vascular disease. Lancet 1973; I: 155-6.
2. Carlson LA, Olsson A. Intravenous prostaglandin E in severe peripheral vascular disease. Lancet 1976; II: 810.
3. 2 and mimetics in patients with peripheral vascular disease. Progr Clin Biol Res 1989; 301: 85-96.
4. 1. J Pharmacol Exp Therap 1967; 156: 538-47.
5. 1 in der Behandlung der peripheren arteriellen Verschlußkrankheit. Wien Klin Wochenschr 1991; 103: 558-65.
6. Lambert J, Lambert PJ. Untoward hemodynamic effects of intra-arterial injections of vasodilator drugs on the muscle circulation in the dog hind limb with experimental arterial occlusion. Angiology 1967; 18: 415-27.
7. Hansteen V, Lorentsen E. Vasodilator drugs in the treatment of peripheral arterial insufficiency. Acta Med Scand 1974; Suppl 556: S3-S62.
8. Coffman JD. Vasodilator drugs in peripheral vascular disease. N Engl J Med 1979; 300: 713-7.
9. Ranke C, Hendrickx P, Roth U, Brassel F, Creutzig A, Alexander K. Color and conventional image-directed Doppler ultrasonography: Accuracy and sources of error in quantitative blood flow measurements. J Clin Ultrasound 1992; 20: 187-93.
10. Sumner DS. Volume plethysmography in vascular disease: an overview. In: Bernstein EF, editor. Noninvasive diagnostic techniques in vascular disease. St Louis: Mosby, 1985: 97-118.
11. Lassen NA, Lindbjerg J, Munck O. Measurement of blood-flow through skeletal muscle by intramuscular injection of Xenon-133. Lancet 1964; 1: 686-9.
12. Huang SC, Carson RE, Hoffman EJ, Carson J, MacDonald N, Barrio JR, Phelps ME. Quantitative measurement of local cerebral blood flow in humans by positron computed tomography and 15-O-water. J Cereb Blood Flow Metab 1983; 3: 141-53.
13. Bergmann SR, Sobel BE (editors). Positron emission tomography of the heart. Mount Kisco, NY: Futura Publishing Inc., 1992
14. Strauss LG, Conti PS. The application of PET in clinical oncology. J Nucl Med 1991; 32: 623-48.
15. Bergmann SR, Fox KA, Rand AL, McElvany KD, Welch MJ, Markham J, Sobel BE. Quantification of regional myocardial blood flow in vivo with H2-15-O. Circulation 1984; 70: 724-33.
16. Burchert W, Schellong SM, van den Hoff J, Meyer GJ, Alexander K, Hundeshagen H. Oxygen-15-water PET assessment of muscular blood flow in peripheral vascular disease. J Nucl Med 1997; 38: 93-8.
17. Kety SS, Schmidt CE. The nitrous oxide method for the quantitative determination of cerebral blood flow in man: theory, procedure and normal values. J Clin Invest 1948; 27: 476-83.
18. van den Hoff J, Burchert W, Müller-Schauenburg W, Meyer GJ, Hundeshagen H. Accurate local blood flow measurements with dynamic PET: fast determination of input function delay and dispersion by multilinear minimization. J Nucl Med 1993; 34: 1770-7.
19. 1 and canine hind limb blood flow. Curr Surg 1983; 40: 289-91.
20. 1 on canine hindlimb blood flow distribution. Surgery 1984; 96: 35-41.
21. Lassen NA, Holstein P. Use of radioisotopes in assessment of distal blood flow and distal blood pressure in arterial insufficiency. Surg Clin North Am 1974; 54: 39-55.
22. Nielsen PE, Nielsen SL, Holstein P, Poulsen HL, Hansen EH, Lassen NA. Intra-arterial infusion of prostaglandin E in normal subjects and patients with peripheral arterial disease. Scand J Clin Lab Invest 1976; 36: 633-40.
23. 1 in healthy subjects. Klin Wochenschr 1985; 63: 1201-4.
24. 1 in patients with peripheral arterial disease. Br J Surg 1986; 73: 20-3.
25. Bergström S, Duner H, v. Euler US, Pernow B, Sjövall J. Observations on the effects of infusion of Prostaglandin E in man. Acta Physiol Scand 1959; 45: 145-51.
26. 1 on blood pressure and heart rate in the dog. Acta Physiol Scand 1966; 67: 89-99.
27. 1 in man. J Clin Invest 1975; 56: 1404-10.
28. 1 administered intravenously to human volunteers. J Physiol Pharmacol 1991; 42: 327-31.
29. 1. Eur J Pharmacol 1971; 14: 66-70.
30. 2a on ADP-induced aggregation of human and rabbit platelets. Br J Pharmacol 1976; 58: P297-P298.
31. 1. VASA Suppl 1991; 33: 337-8.
32. 1 in patients with arterial occlusive disease. Klin Wochenschr 1990; 68: 207-12.
33. 2. Naunyn-Schmiedebergs Arch Pharmacol 1990; 341: 308-15.
34. 2 on the human erythrocyte as monitored by spin labels. Biochem Biophys Res Commun 1974; 56: 478-83.
35. 1 on platelet behaviour in vitro and in vivo. Br Med J 1967; 2: 468-72.
36. 1 - an update. VASA 1989; 28 Suppl: 14-8..